Adrián Lázaro-Frías

COVID-19 Vaccine Candidates Based on Modified Vaccinia Virus Ankara Expressing the SARS-CoV-2 Spike Protein Induce Robust T- and B-Cell Immune Responses and Full Efficacy in Mice

Juan García‐Arriaza, Urtzi Garaigorta, Patricia Pérez et al. · Journal of Virology · 2021 · 105 citations · Full text

A Vaccine Based on a Modified Vaccinia Virus Ankara Vector Expressing Zika Virus Structural Proteins Controls Zika Virus Replication in Mice

Patricia Pérez, María Q. Marín, Adrián Lázaro-Frías et al. · Scientific Reports · 2018 · 53 citations · Full text

Distinct Immunogenicity and Efficacy of Poxvirus-Based Vaccine Candidates against Ebola Virus Expressing GP and VP40 Proteins

Adrián Lázaro-Frías, Sergio Gómez‐Medina, Lucas Sánchez-Sampedro et al. · Journal of Virology · 2018 · 40 citations · Full text

Full efficacy and long-term immunogenicity induced by the SARS-CoV-2 vaccine candidate MVA-CoV2-S in mice

Adrián Lázaro-Frías, Patricia Pérez, Carmen Zamora et al. · npj Vaccines · 2022 · 29 citations · Full text

Vaccination, Vaccine Development, Vaccine Target +13

A Single Dose of an MVA Vaccine Expressing a Prefusion-Stabilized SARS-CoV-2 Spike Protein Neutralizes Variants of Concern and Protects Mice From a Lethal SARS-CoV-2 Infection

Patricia Pérez, Adrián Lázaro-Frías, Carmen Zamora et al. · Frontiers in Immunology · 2022 · 28 citations · Full text

Vaccination, Mva Poxvirus Vector, Protects Mice +15